Myelitis: Clinical Trials

4 trials for Myelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 4
Phase 21Recruiting 1

Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants
nOPV2 - Poliomyelitis
Phase 3RecruitingFidec Corporation7402026-04-302026-09-09
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
High-dose corticosteroids (HDCS), High-dose corticosteroids (HDCS) and PLEX - Optic Neuritis, Myelitis
Phase 3RecruitingMayo Clinic3822025-07-112026-09-24
Azathioprine in MOGAD
Azathioprine, Placebo - Central Nervous System Inflammation, MOG-IgG Associated Disease
Phase 3RecruitingHospices Civils de Lyon1262023-12-122025-02-04
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Vibegron - Neurogenic Detrusor Overactivity
Phase 2 / Phase 3RecruitingUrovant Sciences GmbH712022-10-122026-06-15

Narrower conditions

Myelitis, Transverse (2)  ·  Optic Neuritis (2)  ·  Meningocele (1)  ·  Meningomyelocele (1)  ·  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1)  ·  Neuromyelitis Optica (1)  ·  Poliomyelitis (1)  ·  Spinal Cord Injuries (1)  ·  Spinal Dysraphism (1)

Broader conditions

Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Infections (4)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Spinal Cord Diseases (4)  ·  Autoimmune Diseases (3)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Demyelinating Autoimmune Diseases, CNS (3)  ·  Demyelinating Diseases (3)  ·  Immune System Diseases (3)  ·  Cranial Nerve Diseases (2)  ·  Eye Diseases (2)  ·  Neoplasms (2)

Interventions

Adrenal Cortex Hormones (1)  ·  Azathioprine (1)  ·  N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide (1)

Sponsors

Fidec Corporation (1)  ·  Hospices Civils de Lyon (1)  ·  Mayo Clinic (1)  ·  Urovant Sciences GmbH (1)

Countries

United States (2)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Canada (1)  ·  Croatia (1)  ·  Denmark (1)  ·  France (1)  ·  Georgia (1)  ·  Jordan (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Malaysia (1)  ·  Philippines (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

Janet Owens-Grillo (1)  ·  John Chen (1)  ·  Khaelqu Zaman, Dr. (1)